QBE share price rises despite expected half year loss

The QBE share price has risen today despite the insurer announcing it expects a net loss for the half year to 30 June 2020.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The QBE Insurance Group Ltd (ASX: QBE) share price rose 2.8% this morning before being sold off to now trade at a modest 1.7% gain. This was despite the insurer announcing it expects to report a net loss for the half year to 30 June 2020. QBE has forecast a statutory loss after tax of around $750 million for the half year. 

business man turning out empty pockets

Image source: Getty Images

Impacts of COVID-19 

COVID-19 is expected to have an underwriting impact of $335 million. This includes $150 million of net incurred claims, $115 million in additional risk margin, $50 million in premium concessions and $20 million of expenses including motor vehicle premium refunds. The pandemic has impacted multiple lines of business including property (business interruption), reinsurance, workers' compensation, trade credit, and lenders mortgage insurance. 

The benefit of reduced personal motor claims frequency was returned to customers through premium refunds. While the landscape remains uncertain, QBE currently estimates total COVID-19 related costs will be around $600 million pre-tax. This includes $265 million of potential further net claims that could emerge over the next 12 – 18 months, as well as a net investment loss of around $125 million as a result of extreme market volatility. 

Catastrophe and prior accident claims 

Catastrophe claims increased to $310 million during the half, up from $180 million in 1H FY19. This exceeded QBE's $250 million allowance and reflected the devastating impacts of the bushfires in Australia coupled with east coast storm and hail activity. The half year result will also include adverse net prior accident year claims development of around $120 million. Lower risk-free rates used to discount net outstanding claims are expected to impact the underwriting result by around $335 million. 

How has the QBE share price been performing? 

The QBE share price fell from a February high of over $15 to a low of $7.32 in March. It has since recovered 34% to currently trade at $9.83. This is slightly ahead of the broader S&P/ASX 200 (ASX: XJO) which has recovered 33% from its March low. QBE conducted an $825 million capital raise in April in order to lift its regulatory capital. This provided the company with the capital strength to navigate a range of severe economic scenarios. 

Despite the disruption caused by the pandemic, insurance trading conditions have strengthened, with renewal rate increases averaging 8.7% during the half compared with 4.7% during 1H FY19. QBE Group CEO, Pat Regan, said, "Despite the impact of COVID-19, I am encouraged by the strong underlying trends evident in the result. Notwithstanding significant uncertainty surrounding the enduring impact of the COVID-19 pandemic, our greatly strengthened capital base positions us well to capitalise on accelerating pricing momentum and emerging organic growth opportunities".  

Motley Fool contributor Kate O'Brien has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Morgans names 3 ASX shares to buy now

The broker is feeling bullish on these shares this week.

Read more »

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

Investors continued to pull the markets back up today.

Read more »

Close-up photo of a human hand with $100 bills offering the money to another human hand.
Capital Raising

Why this ASX healthcare stock has crashed 20% today

The Imugene share price is plunging after announcing a heavily discounted capital raising.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Opinions

5 ASX shares I'd buy with $5,000 today

These are the shares I'd be buying right now.

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Harvey Norman shares

A leading investment analyst forecasts mounting headwinds for Harvey Norman shares.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Broker Notes

With half year profits up 9% to $1.6 billion, are Wesfarmers shares a buy?

A top investment expert provides his outlook for Wesfarmers shares.

Read more »

Broker looking at the share price.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

Why Breville, Forrestania Resources, GQG Partners, and WiseTech shares are falling today

These shares are having a tough time on hump day. But why?

Read more »